Patent directory · USPTO A61K / A61P
Patents matching “therapy”
782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6696064
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy
expired -
US 6683058
Methods for therapy of neurodegenerative disease of the brain
expired -
US 6669935
Delivery of therapeutic agents by gene therapy
expired -
US 6667041
Use of neurotoxin therapy for treatment of urologic and related disorders
expired -
US 6660750
Flavopiridol methods and compositions for HIV therapy
expired -
US 6653351
Adjuvant chemotherapy for anaplastic gliomas
expired -
US 6638543
Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
expired -
US 6630124
Combination therapy with VIP antagonist
expired -
US 6627615
Methods and compositions for in vivo gene therapy
expired -
US 6613757
COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY
expired -
US 6579857
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
expired -
US 6576463
Hybrid vectors for gene therapy
expired -
US 6565827
Radioimmunotherapy of lymphoma using anti-CD20 antibodies
expired -
US 6566342
Gene therapy by secretory gland expression
expired -
US 6551588
Tumor radiosensitization using gene therapy
expired -
US 6548055
Immunologic enhancement with intermittent interleukin-2 therapy
expired -
US 6514695
Compositions and methods for intraductal gene therapy
expired -
RU 2191009
METHODS OF THERAPY BY APPLYING THE COMPOUNDS EITHER OF SPECIFIC OR SELECTIVE ACTIVITY TO RETINAL ACID RECEPTOR RARalpha
expired -
US 6451306
Methods for therapy of neurodegenerative disease of the brain
expired -
US 6426076
Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy
expired -
US 6423311
Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
expired -
US 6417338
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
expired -
US 6403771
Method and means for site directed therapy
expired -
US 6395712
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
expired